Browsing publications by Professor Anthony Moorman

Newcastle AuthorsTitleYearFull text
Dr Sarra Ryan
Elizabeth Matheson
Dr Paul Sinclair
Dr Matthew Bashton
Claire Schwab
et al.
The role of the RAS pathway in iAMP21-ALL2016
Dr Alem Gabriel
Dr Amir Enshaei
Jennifer Taylor
Dr Amy Erhorn
Claire Schwab
et al.
Age specific incidence of partner gene and secondary abnormalities in MLL positive acute lymphoblastic leukaemia (ALL)2015
Dr Lisa Russell
Lisa Jones
Dr Amir Enshaei
Jamie Rutherford
Dr Stefano Tonin
et al.
Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia2015
Professor Anthony Moorman
Dr Julie Irving
Dr Amir Enshaei
Dr Amy Erhorn
Lynne Minto
et al.
Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia2015
Dr Alem Gabriel
Dr Ed Schwalbe
Sirintra Nakjang
Dr Simon Cockell
Alice Iliasova
et al.
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia2015
Dr Amir Enshaei
Professor Anthony Moorman
Professor Christine Harrison
Dr Sujith Samarasinghe
Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD: Results from a Large Multi-Center Randomized Controlled Trial, UKALL 20032015
Claire Schwab
Dr Amir Enshaei
Professor Anthony Moorman
Prognostic value of rare IKZF1 deletion in childhood b-cell precursor acute lymphoblastic leukemia: an international collaborative study2015
Dr Amir Enshaei
Claire Schwab
Dr Lucy Chilton
Professor Anthony Moorman
Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy2015
Claire Schwab
Alannah Elliott
Dr Lucy Chilton
Professor Anthony Moorman
Professor Christine Harrison
et al.
Targeted Sequencing Identifies Association Between IL7R-JAK Mutations And Epigenetic Modulators In T-Cell Acute Lymphoblastic Leukemia.2015
Professor Anthony Moorman
Dr Julie Irving
Professor James Allan
Professor Christine Harrison
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A2015
12345678910111213141516